Archiv | Archiv 2018 | ESMO 2018

Welcome to Munich

ESMO 2018

Welcome to munich

Dr. med. Friedrich Overkamp

Kolorektales Karzinom

ESMO 2018

Adjuvante Therapie: Liquid Biopsy & MOSAIC trial

Prof. Dr. med. Anke Reinacher-Schick

ESMO 2018

Kolonkarzinom

Prof. Dr. med. Dirk Arnold

ESMO 2018

CRC

PD Dr. med. Dominik Modest

ESMO 2018

Adjuvante Therapie: Liquid Biopsy

Prof. Dr. med. Anke Reinacher-Schick

ESMO 2018

metastasiertes Analkarzinom

Prof. Dr. med. Dirk Arnold

ESMO 2018

VOLFI trial & NORDIC9

Prof. Dr. med. Anke Reinacher-Schick

Mammakarzinom

ESMO 2018

PALOMA 3 Update

PD Dr. med. Hans-Christian Kolberg

ESMO 2018

CDK4/6 QoL und OS Update

Prof. Dr. med. Peter Fasching

ESMO 2018

IMpassion130

Prof. Dr. med. Diana Lüftner

ESMO 2018

Alpelisib (ALP) + fulvestrant (FUL): SOLAR-1 trial

PD Dr. med. Hans-Christian Kolberg

ESMO 2018

SOLO 1

Prof. Dr. med. Peter Fasching

ESMO 2018

CDK 4/6 Update

Prof. Dr. med. Diana Lüftner

ESMO 2018

IMpassion130 atezolizumab + nab-paclitaxel in mTNBC

Prof. Dr. med. Peter Fasching

ESMO 2018

PD-L1-doch wieder ein Marker?

Prof. Dr. med. Peter Fasching

ESMO 2018

Update Quality of Life

PD Dr. med. Hans-Christian Kolberg

Melanom

ESMO 2018

Melanom - neoadjuvante Therapie: OpACIN-neo

Dr. med. Elisabeth Livingstone

ESMO 2018

Update Combi-AD-Biomarker

Dr. med. Elisabeth Livingstone

ESMO 2018

CheckMate 511

Prof. Dr. med. Axel Hauschild

ESMO 2018

Update Combi-AD-adjuvante Therapie

Dr. med. Elisabeth Livingstone

ESMO 2018

Combi-AD

Prof. Dr. med. Axel Hauschild

Urogenitale Tumoren

ESMO 2018

mUC CheckMate 032

Dr. med. Gerson Lüdecke

ESMO 2018

Nierenzellkarzinom JAVELIN Renal 101

Prof. Dr. med. Viktor Grünwald

ESMO 2018

NMIBC KEYNOTE-057

Dr. med. Gerson Lüdecke

Weitere

ESMO 2018

Nobelpreis Checkpoint Inhibitoren

Dr. med. Friedrich Overkamp

ESMO 2018

ASH 2018 Teaser

Dr. Friedrich Overkamp

ESMO 2018

Kopf-Hals-Tumoren

Prof. Dr. med. Viktor Grünwald

ESMO 2018

SABCS 2018 Teaser

Dr. med. Friedrich Overkamp